Anthony Maddaluna - Pfizer Insider

Pfizer Inc -- Germany Stock  

EUR 30.39  0.39  1.27%

Executive Vice President and Presidentident - Pfizer Global Supply

Mr. Anthony J. Maddaluna is Executive Vice President President Pfizer Global Supply of the Company. He was President Pfizer Global Supply from 2011 until December 2012. Senior Vice President Strategy Supply Network Transformation from 2009 until December 2010. Vice President Strategy Supply Network Transformation from 2008 until 2009. Vice President and Team Leader Europe from 1998 until 2008 including responsibility for global logistics and strategic planning from 2005 through 2008
Age: 62  President Since 2013      
Maddaluna represents Pfizer on the National Association of Manufacturers and is a member of the NAM Executive Committee. Director of Albany Molecular Research Inc.

Anthony Maddaluna Latest Insider Activity

Anthony Maddaluna over three months ago via Macroaxis 
Pfizer exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 5.27 % which means that it generated profit of $5.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.68 % meaning that it generated $13.68 on every $100 dollars invested by stockholders.
The company has accumulated 43.87 B in total debt with debt to equity ratio (D/E) of 74.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer Inc has Current Ratio of 1.31 which is within standard range for the sector.

Similar Executives

Entity Summary

Pfizer Inc (PFE) is traded on Frankfurt Stock Exchange in Germany. and employs 28 people.

Did you try this?

Run Focused Opportunities Now
   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Hide  View All  Next  Launch Focused Opportunities
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pfizer Inc to your portfolio

Top Management

Pfizer Inc Leadership Team
John Young, President
Frank DAmelio, President
Douglas Lankler, President
Helen Hobbs, Director, Ph.D
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Suzanne Johnson, Director
Alexander Mackenzie, President
Geno Germano, President
Laurie Olson, President
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
W Cornwell, Director
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President
Kirsten LundJurgensen, President
Ronald Blaylock, Director
Kathrin Jansen, President, Ph.D

Stock Performance

Pfizer Performance Indicators